anti-CD3 antibody

With no partner, MorphoSys drops MOR202 in myeloma
Biopharma Dive
Fri, 08/3/18 - 10:53 pm
MorphoSys
earnings
anti-CD3 antibody
MOR202
Exclusive: Tolerx cuts staff, auctioning assets after PhIII failure
Fierce Biotech
Fri, 10/7/11 - 10:56 am
Tolerx
layoffs
otelixizumab
GSK
anti-CD3 antibody